Fig. 1From: Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonatesMean percent changes in bone density from baseline during TPTD treatment. Changes over time in a Lumbar spine YAM; b Femoral neck YAM; c Lumbar spine BMD; d Femoral neck BMD. Results were compared using †ANOVA and ‡Wilcoxon matched-pairs single rank test; *p < 0.05; bars indicate 95 % CIBack to article page